Advertisement

 

 

Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals.

Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals.
Author Information (click to view)

Grant PM, Kitch D, McComsey GA, Collier AC, Koletar SL, Erlandson KM, Yin MT, Bartali B, Ha B, Melbourne K, Brown TT,


Grant PM, Kitch D, McComsey GA, Collier AC, Koletar SL, Erlandson KM, Yin MT, Bartali B, Ha B, Melbourne K, Brown TT, (click to view)

Grant PM, Kitch D, McComsey GA, Collier AC, Koletar SL, Erlandson KM, Yin MT, Bartali B, Ha B, Melbourne K, Brown TT,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

The Journal of infectious diseases 2016 06 20214(4) 607-11 doi 10.1093/infdis/jiw204

Abstract

We compared adjusted bone mineral density (BMD) changes between human immunodeficiency virus (HIV)-infected individuals during the first approximately 7.5 years after antiretroviral therapy (ART) initiation and HIV-uninfected controls. HIV-infected individuals (n = 97) had significantly greater adjusted BMD decline than controls (n = 614) during the first 96 weeks of ART. Subsequently, the rate of BMD decline slowed in HIV-infected individuals but remained greater than the rate of decline in HIV-uninfected individuals at the lumbar spine but not at the hip. In HIV-infected individuals after 96 weeks, no HIV- or treatment-related characteristic was associated with BMD loss, but lower lean body mass was associated with greater BMD loss at both lumbar spine and hip.

Submit a Comment

Your email address will not be published. Required fields are marked *

16 − nine =

[ HIDE/SHOW ]